NAVBO Newsletter, Summer 2017
Member News - Hyperlinks for member articles
Princess U II Imoukhuede, Ph.D., Assistant Professor of Bioengineering at the University of Illinois at Urbana-Champaign, has been awarded a National Science Foundation CAREER award for her proposal, “qBio+cBio=sBio: Identifying the Role of Cross-Family Signaling in Angiogenesis.” Dr. Imoukhuede also received the Rose Award for Teaching ExcellenceExcellence from the University of Illinois College of Engineering.
In October of 2016, Iris Jaffe of Tufts University assumed the role of Executive Director of the Molecular Cardiology Research Institute at Tufts Medical Center. In March of this year, Dr. Jaffe was also appointed as the Eliza Kent Mendelsohn Professor of Molecular CardiologyKent Mendelsohn Professor of Molecular Cardiology. Dr. Jaffe’s research combines her expertise in gene transcription and vascular biology with her interests as a clinical cardiologist to explore the molecular mechanisms that contribute to common cardiovascular diseases.
José López, M.D. Professor of Medicine-Hematology at the University of Washington School of Medicine, has co-edited a book, Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: an Update, published in 2017 by Springer (ISBN 978-3-319-47462-5). This volume reviews current science and applications in fields including thrombosis and hemostasis, signal transduction, and non-thrombotic conditions such as inflammation, allergy and tumor metastasis.
Fortune Magazine has recognized Laura Niklason, M.D., Ph.D., Nicholas M. Greene Professor in Anesthesia and Biomedical Engineering at Yale University and founder of Humacyte, Inc., as a member of Fortune’s List of Leaders Transforming Health and Medicine. Dr. Niklason and her colleagues at Humacyte have developed bioengineered blood vessels currently under investigation as vascular grafts in patients with kidney failure. In addition, Dr. Niklason was inducted into the National Academy of Medicine in October of 2016.
Dr. Bing Zhang has relocated from Boston Children’s Hospital to Shanghai Jiao Tong University as Professor and Principal Investigator in the Shanghai Center for Systems Biomedicine. Dr. Zhang subsequently was recognized through China’s Thousand Talents Plan that seeks to recruit “…strategic scientists or leading talents who can make breakthroughs in key technologies or can enhance China’s high-tech industries and emerging